CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects
Clinical trial NCT03446976 · COMPLETED
Trial details
- NCT number
- NCT03446976
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2018-07-26
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.